Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie M Decker

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Plos One|March 31, 2010
4E10-resistant HIV-1 isolated from four subjects with rare membrane-proximal external region polymorphismsKyle J Nakamura, Johannes S Gach, Laura Jones, et al.
Journal of Virology|March 16, 2007
Unique mutational patterns in the envelope alpha 2 amphipathic helix and acquisition of length in gp120 hypervariable domains are associated with resistance to autologous neutralization of subtype C human immunodeficiency virus type 1Rong Rong, S Gnanakaran, Julie M Decker, et al.
Virology|December 17, 2009
A rev1-vpu polymorphism unique to HIV-1 subtype A and C strains impairs envelope glycoprotein expression from rev-vpu-env cassettes and reduces virion infectivity in pseudotyping assaysMatthias H Kraus, Nicholas F Parrish, Katharina S Shaw, et al.
Journal of Virology|August 31, 2012
Epitope mapping of broadly neutralizing HIV-2 human monoclonal antibodiesRui Kong, Hui Li, Ivelin Georgiev, et al.
Journal of Virology|July 1, 2011
Phenotypic and immunologic comparison of clade B transmitted/founder and chronic HIV-1 envelope glycoproteinsCraig B Wilen, Nicholas F Parrish, Jennifer M Pfaff, et al.
Nature|March 21, 2003
Antibody neutralization and escape by HIV-1Xiping Wei, Julie M Decker, Shuyi Wang, et al.
Journal of Virology|July 30, 2005
Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodiesMing Li, Feng Gao, John R Mascola, et al.
Journal of Virology|February 6, 2009
In vivo gp41 antibodies targeting the 2F5 monoclonal antibody epitope mediate human immunodeficiency virus type 1 neutralization breadthXiaoying Shen, Robert J Parks, David C Montefiori, et al.
Journal of Virology|May 12, 2007
Generation of infectious molecular clones of simian immunodeficiency virus from fecal consensus sequences of wild chimpanzeesJun Takehisa, Matthias H Kraus, Julie M Decker, et al.
The Journal of Experimental Medicine|May 4, 2005
Antigenic conservation and immunogenicity of the HIV coreceptor binding siteJulie M Decker, Frederic Bibollet-Ruche, Xiping Wei, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Plos One|March 31, 2010
4E10-resistant HIV-1 isolated from four subjects with rare membrane-proximal external region polymorphismsKyle J Nakamura, Johannes S Gach, Laura Jones, et al.
Journal of Virology|March 16, 2007
Unique mutational patterns in the envelope alpha 2 amphipathic helix and acquisition of length in gp120 hypervariable domains are associated with resistance to autologous neutralization of subtype C human immunodeficiency virus type 1Rong Rong, S Gnanakaran, Julie M Decker, et al.
Virology|December 17, 2009
A rev1-vpu polymorphism unique to HIV-1 subtype A and C strains impairs envelope glycoprotein expression from rev-vpu-env cassettes and reduces virion infectivity in pseudotyping assaysMatthias H Kraus, Nicholas F Parrish, Katharina S Shaw, et al.
Journal of Virology|August 31, 2012
Epitope mapping of broadly neutralizing HIV-2 human monoclonal antibodiesRui Kong, Hui Li, Ivelin Georgiev, et al.
Journal of Virology|July 1, 2011
Phenotypic and immunologic comparison of clade B transmitted/founder and chronic HIV-1 envelope glycoproteinsCraig B Wilen, Nicholas F Parrish, Jennifer M Pfaff, et al.
Nature|March 21, 2003
Antibody neutralization and escape by HIV-1Xiping Wei, Julie M Decker, Shuyi Wang, et al.
Journal of Virology|July 30, 2005
Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodiesMing Li, Feng Gao, John R Mascola, et al.
Journal of Virology|February 6, 2009
In vivo gp41 antibodies targeting the 2F5 monoclonal antibody epitope mediate human immunodeficiency virus type 1 neutralization breadthXiaoying Shen, Robert J Parks, David C Montefiori, et al.
Journal of Virology|May 12, 2007
Generation of infectious molecular clones of simian immunodeficiency virus from fecal consensus sequences of wild chimpanzeesJun Takehisa, Matthias H Kraus, Julie M Decker, et al.
The Journal of Experimental Medicine|May 4, 2005
Antigenic conservation and immunogenicity of the HIV coreceptor binding siteJulie M Decker, Frederic Bibollet-Ruche, Xiping Wei, et al.
Pageof 5